PT100344A - Factores polipeptidicos mitogenicos gliais, e seu processo de preparacao, ensaio da actividade mitogenica, sequencias de adn que codificam os factores e construcoes de adn que as compreendem, celulas hospedeiras, formulacoes farmaceutica ou veterinaria, uso dos polipeptidos, anticorpo, e sequencia genetica codificando actividade mitogenica de celulas gliais. - Google Patents

Factores polipeptidicos mitogenicos gliais, e seu processo de preparacao, ensaio da actividade mitogenica, sequencias de adn que codificam os factores e construcoes de adn que as compreendem, celulas hospedeiras, formulacoes farmaceutica ou veterinaria, uso dos polipeptidos, anticorpo, e sequencia genetica codificando actividade mitogenica de celulas gliais.

Info

Publication number
PT100344A
PT100344A PT100344A PT10034492A PT100344A PT 100344 A PT100344 A PT 100344A PT 100344 A PT100344 A PT 100344A PT 10034492 A PT10034492 A PT 10034492A PT 100344 A PT100344 A PT 100344A
Authority
PT
Portugal
Prior art keywords
factors
glitary
mitogenic
dna
mitogenics
Prior art date
Application number
PT100344A
Other languages
English (en)
Other versions
PT100344B (pt
Inventor
Andrew David John Goodearl
Michael Derek Waterfield
Paul Stroobant
Luisa Minghetti
Mark Andrew Marchionni
Original Assignee
Ludwig Inst Cancer Res
Cambridge Neuroscience Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ludwig Inst Cancer Res, Cambridge Neuroscience Inc filed Critical Ludwig Inst Cancer Res
Publication of PT100344A publication Critical patent/PT100344A/pt
Publication of PT100344B publication Critical patent/PT100344B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/4756—Neuregulins, i.e. p185erbB2 ligands, glial growth factor, heregulin, ARIA, neu differentiation factor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Hospice & Palliative Care (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Psychiatry (AREA)
  • Biochemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
PT100344A 1991-04-10 1992-04-03 Factores polipeptidicos mitogenicos gliais, e seu processo de preparacao, ensaio da actividade mitogenica, sequencias de adn que codificam os factores e construcoes de adn que as compreendem, celulas hospedeiras, formulacoes farmaceutica ou veterinaria, uso dos polipeptidos, anticorpo, e sequencia genetica codificando actividade mitogenica de celulas gliais. PT100344B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919107566A GB9107566D0 (en) 1991-04-10 1991-04-10 Glial mitogenic factors,their preparation and use

Publications (2)

Publication Number Publication Date
PT100344A true PT100344A (pt) 1993-07-30
PT100344B PT100344B (pt) 1999-08-31

Family

ID=10692987

Family Applications (1)

Application Number Title Priority Date Filing Date
PT100344A PT100344B (pt) 1991-04-10 1992-04-03 Factores polipeptidicos mitogenicos gliais, e seu processo de preparacao, ensaio da actividade mitogenica, sequencias de adn que codificam os factores e construcoes de adn que as compreendem, celulas hospedeiras, formulacoes farmaceutica ou veterinaria, uso dos polipeptidos, anticorpo, e sequencia genetica codificando actividade mitogenica de celulas gliais.

Country Status (13)

Country Link
EP (1) EP0579640B1 (pt)
JP (1) JPH06507544A (pt)
KR (1) KR100274305B1 (pt)
AT (1) ATE221083T1 (pt)
AU (2) AU1450992A (pt)
CA (1) CA2108119C (pt)
DE (1) DE69232693T2 (pt)
DK (1) DK0579640T3 (pt)
GB (1) GB9107566D0 (pt)
IE (1) IE921062A1 (pt)
PT (1) PT100344B (pt)
WO (1) WO1992018627A1 (pt)
ZA (1) ZA922441B (pt)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5530109A (en) * 1991-04-10 1996-06-25 Ludwig Institute For Cancer Research DNA encoding glial mitogenic factors
IL101943A0 (en) * 1991-05-24 1992-12-30 Genentech Inc Structure,production and use of heregulin
US5834229A (en) * 1991-05-24 1998-11-10 Genentech, Inc. Nucleic acids vectors and host cells encoding and expressing heregulin 2-α
US5367060A (en) * 1991-05-24 1994-11-22 Genentech, Inc. Structure, production and use of heregulin
EP0656069A4 (en) * 1992-08-10 1996-07-10 Cambridge Neuroscience Inc CELL PROLIFERATION INHIBITORS, THEIR PRODUCTION AND USE.
GB9217316D0 (en) * 1992-08-14 1992-09-30 Ludwig Inst Cancer Res Schwann cell mitogenic factor,its preparation and use
US5770567A (en) * 1994-11-14 1998-06-23 Genentech, Inc. Sensory and motor neuron derived factor (SMDF)
US5849585A (en) * 1995-05-10 1998-12-15 Genetech, Inc. Isolating and culturing Schwann cells
US6033660A (en) * 1995-05-10 2000-03-07 Genentech, Inc. Method of treating a nervous system injury with cultured schwann cells
US5721139A (en) * 1995-05-10 1998-02-24 Genentech, Inc. Isolating and culturing schwann cells
US5912326A (en) * 1995-09-08 1999-06-15 President And Fellows Of Harvard College Cerebellum-derived growth factors
ATE290595T1 (de) 1996-07-12 2005-03-15 Genentech Inc Gamma-heregulin
US6136558A (en) * 1997-02-10 2000-10-24 Genentech, Inc. Heregulin variants
WO1998035036A1 (en) 1997-02-10 1998-08-13 Genentech, Inc. Heregulin variants
WO1999031505A1 (en) * 1997-12-15 1999-06-24 Shire Laboratories Inc. Neurotrophic factor assay
US20010023241A1 (en) 1998-02-04 2001-09-20 Sliwkowski Mark X. Use of heregulin as a growth factor
AUPP785098A0 (en) 1998-12-21 1999-01-21 Victor Chang Cardiac Research Institute, The Treatment of heart disease
US6635249B1 (en) 1999-04-23 2003-10-21 Cenes Pharmaceuticals, Inc. Methods for treating congestive heart failure
ITMI20011057A1 (it) 2001-05-22 2002-11-22 Bracco Imaging Spa Preparazione ed uso di peptidi ciclici e ramificati e loro deriati marcati come agenti terapeutici agonisti o antagonisti della colecistochi
WO2003099320A1 (en) 2002-05-24 2003-12-04 Zensun (Shanghai) Sci-Tech.Ltd Neuregulin based methods and compositions for treating viral myocarditis and dilated cardiomyopathy
US7241392B2 (en) 2004-09-09 2007-07-10 Dresser-Rand Company Rotary separator and method
US20070213264A1 (en) 2005-12-02 2007-09-13 Mingdong Zhou Neuregulin variants and methods of screening and using thereof
EP3363455A1 (en) 2005-12-30 2018-08-22 Zensun (Shanghai) Science & Technology, Co., Ltd. Extended release of neuregulin for improved cardiac function
EP2328606B1 (en) 2008-08-15 2016-10-05 Acorda Therapeutics, Inc. Compositions and methods for treatment during non-acute periods following cns neurological injury
WO2013053076A1 (en) 2011-10-10 2013-04-18 Zensun （Shanghai）Science & Technology Limited Compositions and methods for treating heart failure
EP3610905B1 (en) 2013-05-22 2021-03-31 Zensun (Shanghai) Science & Technology, Co., Ltd. Extended release of neuregulin for treating heart failure

Also Published As

Publication number Publication date
AU1450992A (en) 1992-11-17
EP0579640A1 (en) 1994-01-26
JPH06507544A (ja) 1994-09-01
EP0579640B1 (en) 2002-07-24
PT100344B (pt) 1999-08-31
WO1992018627A1 (en) 1992-10-29
DE69232693T2 (de) 2003-04-03
AU703772B2 (en) 1999-04-01
CA2108119C (en) 2009-06-30
ZA922441B (en) 1992-11-25
ATE221083T1 (de) 2002-08-15
DE69232693D1 (de) 2002-08-29
KR100274305B1 (ko) 2000-12-15
AU6808396A (en) 1997-01-16
IE921062A1 (en) 1992-10-21
GB9107566D0 (en) 1991-05-29
CA2108119A1 (en) 1992-10-11
DK0579640T3 (da) 2002-11-11

Similar Documents

Publication Publication Date Title
PT100344A (pt) Factores polipeptidicos mitogenicos gliais, e seu processo de preparacao, ensaio da actividade mitogenica, sequencias de adn que codificam os factores e construcoes de adn que as compreendem, celulas hospedeiras, formulacoes farmaceutica ou veterinaria, uso dos polipeptidos, anticorpo, e sequencia genetica codificando actividade mitogenica de celulas gliais.
BR9907259A (pt) Compostos para terapia e diagnóstico de câncer de pulmão e processos para o seu uso
FI97809B (fi) Rekombinantti-DNA-molekyyli, joka koodaa kudosperäisen plasminogeenin aktivaattorin (TPA) analogia
RU95115239A (ru) Аналог эритропоэтина
ES2121915T3 (es) Ligandos del receptor eck.
BR0009505A (pt) Compostos e processos para terapia e diagnóstico de câncer de pulmão
EP0256092A4 (en) WEAKENED HERPESVIRUSES, HERPESVIRUSES THAT CONTAIN A FOREIGN DNA ENCODING AMINO ACID SEQUENCES, AND VACCINALS THAT CONTAIN THEM.
FI103892B1 (fi) Rekombinantti-DNA-molekyyli, joka koodaa polypeptidiä/proteiinia, jolla on oleellisesti vaskulaaristen antikoaguloivien proteiinien biologiset ominaisuudet sekä niiden valmistus
MX9203379A (es) Proteinas producidas por los linfocitos humanos, secuencia de adn que codifica para estas proteinas y composiciones farmaceuticas que las contienen.
DK288183D0 (da) Fremgangsmade til fremstilling af et oligonucleotidt terapeutisk middel
MX9207334A (es) Acidos nucleicos peptidicos y formulacion farma- ceutica que los contiene
DE3854190D1 (de) Attenuierte herpesviren, herpesviren, die für eine aminosäuresequenz kodierende fremde dns beeinhalten und sie enthaltende impfstoffe.
NO944245L (no) Rekombinante DNA-molekyler som koder for aminopeptidase-enzymer og deres anvendelse ved fremstilling av vaksiner mot helmintinfeksjoner
PT84089B (pt) Sequencias de adn codificando para proteinas possuindo a actividade biologica dos inibidores de husi-tipo i, processos biotecnologicos para a preparacao das referidas proteinas e de composicoes farmaceuticas contendo as referidas proteinas
DE69007616D1 (de) Peptid, immunogene zusammensetzung und impfstoff oder medizinische zubereitung, eine methode zur immunisierung eines säugetieres gegen lhrh und methode zur verbesserung von mea.
FR2726472B1 (fr) Proteine porteuse a effet adjuvant, complexe immunogene la contenant, leur procede de preparation, sequence nucleotidique et vaccin
WO1998011234A3 (en) Human protein kinases
DK0775746T3 (da) Vaccine mod fjerkræcoccidiose
Tijane et al. Octameric structure of yeast phosphofructokinase as determined by crosslinking with disuccinimidyl β‐hydromuconate
DK0709460T3 (da) Fjerkrævaccine imod coccidiosis
BR9807332A (pt) Antìgenos de leishmania para utilização na terapia e diagnóstico de leishmaniose
SG128403A1 (en) Tnf-receptors, tnf binding proteins and dnas coding for them
PT88913A (pt) Processo para a preparacao da proteina pp4-x anticoagulante
ATE407944T1 (de) Mit trp-proteinen verwandtes protein mtr1 und dieses codierende dna-sequenz
BR0110791A (pt) Composição, métodos para induzir uma resposta imune em um indivìduo contra um imunogene, para modular o sistema imune de um indivìduo e para imunizar um indivìduo contra um patógeno, vacina recombinante, e patógeno atenuado vivo

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19930205

FG3A Patent granted, date of granting

Effective date: 19990503

MM4A Annulment/lapse due to non-payment of fees, searched and examined patent

Free format text: MAXIMUM VALIDITY LIMIT REACHED

Effective date: 20140505